Galaxy Therapeutics (Clinical Trial Enrollment)
Funding Details
- Awarder
- RSS - www.prnewswire.com
- Date Award
- May 30, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Traction
- Successful enrollment of primary cohort in a pivotal clinical trial.
- Company Description
- Galaxy Therapeutics is focused on developing innovative therapies for various medical conditions, leveraging advanced biotechnology to improve patient outcomes.
- Market
- Healthcare
- Location
- USA